demonstrated a protective effect in an experimental model of hepatic steatosis [50], in part through the activation of the nuclear factor erythroid 2-related factor 2/antioxidant response element (Nrf2-ARE) signaling pathway. This evidence concerns the gene NFE2L2 and fatty liver disease.